Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 26.6019.6619.3818.6216.82

What is the latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS is 26.60 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202426.60
Mar202319.66
Mar202219.38
Mar202118.62
Mar202016.82

How is EV/Core EBITDA of TORRENT PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 26.6
35.30
Mar2023 19.66
1.44
Mar2022 19.38
4.08
Mar2021 18.62
10.70
Mar2020 16.82 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹110,008.8 Cr 2.3% -0.5% 13.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,176.0 Cr -0.3% -2.9% 11.5% Stock Analytics
DIVIS LABORATORIES ₹177,076.0 Cr 0.7% 7.4% 48.1% Stock Analytics
CIPLA ₹121,592.0 Cr -0.1% 0.2% -2.1% Stock Analytics
DR REDDYS LABORATORIES ₹113,615.0 Cr 3.2% 10.3% 11.7% Stock Analytics
MANKIND PHARMA ₹98,309.9 Cr 1.1% -7% 9.7% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

2.3%

-0.5%

13.8%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses